首页> 外文期刊>BMC Cancer >MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines
【24h】

MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines

机译:MiR-9在自发犬骨肉瘤中过表达,并促进转移表型,包括成骨细胞和骨肉瘤细胞系中的侵袭和迁移

获取原文
           

摘要

Background MicroRNAs (miRNAs) regulate the expression of networks of genes and their dysregulation is well documented in human malignancies; however, limited information exists regarding the impact of miRNAs on the development and progression of osteosarcoma (OS). Canine OS exhibits clinical and molecular features that closely resemble the corresponding human disease and it is considered a well-established spontaneous animal model to study OS biology. The purpose of this study was to investigate miRNA dysregulation in canine OS. Methods We evaluated miRNA expression in primary canine OS tumors and normal canine osteoblast cells using the nanoString nCounter system. Quantitative PCR was used to validate the nanoString findings and to assess miR-9 expression in canine OS tumors, OS cell lines, and normal osteoblasts. Canine osteoblasts and OS cell lines were stably transduced with pre-miR-9 or anti-miR-9 lentiviral constructs to determine the consequences of miR-9 on cell proliferation, apoptosis, invasion and migration. Proteomic and gene expression profiling of normal canine osteoblasts with enforced miR-9 expression was performed using 2D-DIGE/tandem mass spectrometry and RNA sequencing and changes in protein and mRNA expression were validated with Western blotting and quantitative PCR. OS cell lines were transduced with gelsolin (GSN) shRNAs to investigate the impact of GSN knockdown on OS cell invasion. Results We identified a unique miRNA signature associated with primary canine OS and identified miR-9 as being significantly overexpressed in canine OS tumors and cell lines compared to normal osteoblasts. Additionally, high miR-9 expression was demonstrated in tumor-specific tissue obtained from primary OS tumors. In normal osteoblasts and OS cell lines transduced with miR-9 lentivirus, enhanced invasion and migration were observed, but miR-9 did not affect cell proliferation or apoptosis. Proteomic and transcriptional profiling of normal canine osteoblasts overexpressing miR-9 identified alterations in numerous genes, including upregulation of GSN, an actin filament-severing protein involved in cytoskeletal remodeling. Lastly, stable downregulation of miR-9 in OS cell lines reduced GSN expression with a concomitant decrease in cell invasion and migration; concordantly, cells transduced with GSN shRNA demonstrated decreased invasive properties. Conclusions Our findings demonstrate that miR-9 promotes a metastatic phenotype in normal canine osteoblasts and malignant OS cell lines, and that this is mediated in part by enhanced GSN expression. As such, miR-9 represents a novel target for therapeutic intervention in OS.
机译:背景技术MicroRNA(miRNA)调节基因网络的表达,其失调在人类恶性肿瘤中已有很好的记载。但是,关于miRNA对骨肉瘤(OS)发育和进展的影响的信息有限。犬OS表现出与相应的人类疾病非常相似的临床和分子特征,并且被认为是研究OS生物学的公认的自发动物模型。这项研究的目的是调查犬OS中的miRNA失调。方法我们使用nanoString nCounter系统评估了miRNA在原发性犬OS肿瘤和正常犬成骨细胞中的表达。定量PCR用于验证nanoString结果并评估miR-9在犬OS肿瘤,OS细胞系和正常成骨细胞中的表达。用pre-miR-9或抗miR-9慢病毒构建体稳定转导犬成骨细胞和OS细胞系,以确定miR-9对细胞增殖,凋亡,侵袭和迁移的影响。使用2D-DIGE /串联质谱对具有增强的miR-9表达的正常犬成骨细胞进行蛋白质组学和基因表达谱分析,并通过Western印迹和定量PCR验证RNA测序和蛋白质和mRNA表达的变化。用凝溶胶蛋白(GSN)shRNA转导OS细胞系,以研究GSN敲低对OS细胞侵袭的影响。结果我们确定了与原代犬牙OS相关的独特miRNA标记,并且与正常成骨细胞相比,miR-9在犬OS肿瘤和细胞系中明显过表达。另外,在从原发性OS肿瘤获得的肿瘤特异性组织中证实了高miR-9表达。在用miR-9慢病毒转导的正常成骨细胞和OS细胞系中,观察到了增强的侵袭和迁移,但miR-9并不影响细胞增殖或凋亡。正常表达miR-9的正常犬成骨细胞的蛋白质组学和转录谱鉴定出许多基因的改变,包括GSN的上调,GSN是参与细胞骨架重塑的肌动蛋白丝切断蛋白。最后,OS细胞系中miR-9的稳定下调降低了GSN的表达,并伴随着细胞侵袭和迁移的减少。一致地,用GSN shRNA转导的细胞表现出降低的侵袭特性。结论我们的发现表明,miR-9可以促进正常犬成骨细胞和恶性OS细胞系中的转移表型,而这部分是由增强的GSN表达介导的。这样,miR-9代表了OS中治疗干预的新靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号